EGFR-Targeting Nanobodies Released by Stem Cells Reduce Tumor Growth

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-rw2012-169
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

Copper Oxide Nanoparticles Inhibit Pancreatic Tumor Growth Primarily by Targeting Tumor Initiating Cells

Scientific Reports
Multidisciplinary
2019English

Cornering Metastases: Therapeutic Targeting of Circulating Tumor Cells and Stem Cells

Frontiers in Oncology
Cancer ResearchOncology
2012English

Targeting A20 Decreases Glioma Stem Cell Survival and Tumor Growth

PLoS Biology
ImmunologyMolecular BiologyGeneticsBiochemistryMicrobiology Biological SciencesAgriculturalNeuroscience
2010English

PCC0208027, a Novel Tyrosine Kinase Inhibitor, Inhibits Tumor Growth of NSCLC by Targeting EGFR and HER2 Aberrations

Scientific Reports
Multidisciplinary
2019English

582. Ultrasound Gene Delivery to Mesenchymal Stem Cells: Targeting Tumor Therapy

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2011English

Targeting Leukemic Stem Cells by Breaking Their Dormancy

2013English

Targeting Tumor-Initiating Cells: Eliminating Anabolic Cancer Stem Cells With Inhibitors of Protein Synthesis or by Mimicking Caloric Restriction

Oncotarget
Oncology
2015English

Differential Targeting of Stem Cells and Differentiated Glioblastomas by NK Cells

Journal of Cancer
Oncology
2015English

Targeting Pancreatic Cancer Stem Cells

Journal of Cancer Sciences
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy